Helicobacter pylori and gastroesophageal reflux disease: a case-control study.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMC 2714194)

Published in Helicobacter on October 01, 2008

Authors

Douglas A Corley1, Ai Kubo, T R Levin, Gladys Block, Laurel Habel, Gregory Rumore, Charles Quesenberry, Patricia Buffler, Julie Parsonnet

Author Affiliations

1: Division of Research, Kaiser Permanente, Oakland, California 94612-2304, USA. douglas.corley@kp.org

Articles citing this

Irritable bowel syndrome is associated with gastroesophageal reflux symptom but not erosive esophagitis. J Neurogastroenterol Motil (2013) 1.13

Risk factors for erosive esophagitis: a cross-sectional study of a large number of Japanese males. J Gastroenterol (2011) 0.96

Helicobacter pylori Eradication Therapy: Current Availabilities. ISRN Gastroenterol (2012) 0.91

Dissociation and dispersion of claudin-3 from the tight junction could be one of the most sensitive indicators of reflux esophagitis in a rat model of the disease. J Gastroenterol (2011) 0.90

Polymorphism in the Helicobacter pylori CagA and VacA toxins and disease. Gut Microbes (2013) 0.89

Helicobacter pylori: Eradication or Preservation. F1000 Med Rep (2012) 0.89

A review of the epidemiology of Barrett's oesophagus and oesophageal adenocarcinoma. Best Pract Res Clin Gastroenterol (2014) 0.85

Helicobacter pylori Serology Inversely Correlated With the Risk and Severity of Reflux Esophagitis in Helicobacter pylori Endemic Area: A Matched Case-Control Study of 5,616 Health Check-Up Koreans. J Neurogastroenterol Motil (2011) 0.84

Helicobacter pylori infection in older people. World J Gastroenterol (2014) 0.80

Helicobacter pylori Has an Inverse Relationship With Severity of Reflux Esophagitis. J Neurogastroenterol Motil (2011) 0.78

The Gastric Mucosa from Patients Infected with CagA+ or VacA+ Helicobacter pylori Has a Lower Level of Dual Oxidase-2 Expression than Uninfected or Infected with CagA-/VacA- H. pylori. Dig Dis Sci (2016) 0.76

Vegetarianism as a protective factor for reflux esophagitis: a retrospective, cross-sectional study between Buddhist priests and general population. Dig Dis Sci (2013) 0.76

Assessment of gastroesophageal reflux disease by serodiagnosis of Helicobacter pylori-related chronic gastritis stage. World J Gastrointest Endosc (2011) 0.75

Prognostic value of Helicobacter pylori sinonasal colonization for efficacy of endoscopic sinus surgery. Eur Arch Otorhinolaryngol (2012) 0.75

Association of medications for lifestyle-related diseases with reflux esophagitis. Ther Clin Risk Manag (2016) 0.75

Methylation of DAPK and THBS1 genes in esophageal gastric-type columnar metaplasia. World J Gastroenterol (2016) 0.75

Helicobacter pylori Infection in Gastroesophageal Reflux Disease in the Asian Countries. Gastroenterol Res Pract (2015) 0.75

Articles cited by this

Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med (1991) 23.89

Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health (1992) 20.06

Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30

Helicobacter pylori infection and gastric lymphoma. N Engl J Med (1994) 10.26

Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med (1992) 6.64

Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut (1997) 4.70

Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology (2003) 4.52

Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology (2007) 3.94

An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22

A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc (1994) 3.14

Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst (2006) 2.97

Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet (2002) 2.71

Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst (2004) 2.63

The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med (1998) 2.33

Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. J Infect Dis (2005) 2.28

The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology (1998) 2.14

Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative. Am J Gastroenterol (2004) 2.09

Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies. Am J Gastroenterol (2002) 2.09

Gastroesophageal reflux disease. JAMA (1996) 2.09

Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ (2003) 2.04

Gastric cancer, cytotoxin-associated gene A-positive Helicobacter pylori, and serum pepsinogens: an international study. The Eurogst Study Group. Gastroenterology (1999) 1.83

Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut (2001) 1.71

Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma. Clin Gastroenterol Hepatol (2005) 1.65

Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut (2007) 1.57

Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer (2003) 1.55

CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus. Am J Gastroenterol (2000) 1.53

Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology (2001) 1.50

Age-specific incidence of Helicobacter pylori. Gastroenterology (2006) 1.45

Association of Helicobacter pylori genotype with gastroesophageal reflux disease and other upper gastrointestinal diseases. Am J Gastroenterol (2000) 1.36

Seroprevalence of CagA-positive strains among Helicobacter pylori-infected, healthy young adults. J Infect Dis (1997) 1.34

Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Am J Gastroenterol (2000) 1.28

Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis. Am J Gastroenterol (1999) 1.25

Risk factors for Barrett's oesophagus: a population-based approach. Scand J Gastroenterol (2007) 1.16

Four-year trends in Helicobacter pylori IgG serology following successful eradication. Am J Med (1998) 1.10

Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus. Dis Esophagus (1997) 1.08

Retracted Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2003) 1.03

Systematic review of the epidemiological evidence on Helicobacter pylori infection and nonulcer or uninvestigated dyspepsia. Arch Intern Med (2000) 1.03

Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma. Aust N Z J Surg (2000) 1.03

Atrophic gastritis and Helicobacter pylori infection in outpatients referred for gastroscopy. Gut (2000) 1.02

Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori. Cancer Epidemiol Biomarkers Prev (2007) 0.99

Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy. Br Med Bull (1998) 0.98

Helicobacter pylori infection is associated with milder gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2000) 0.97

The Second Canadian Consensus Conference on the Management of Patients with Gastroesophageal Reflux Disease. Can J Gastroenterol (1997) 0.94

Reliability of Helicobacter pylori and CagA serological assays. Clin Diagn Lab Immunol (2002) 0.93

Helicobacter pylori infection and gastroesophageal reflux in a population-based study (The HUNT Study). Helicobacter (2007) 0.93

Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux. Am J Physiol (1999) 0.92

CagA-positive Helicobacter pylori strains may influence the natural history of atherosclerotic stroke. Neurology (2004) 0.89

Relationship of gastric Helicobacter pylori infection to Barrett's esophagus and gastro-esophageal reflux disease in Chinese. World J Gastroenterol (2004) 0.88

Review article: Helicobacter pylori and gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2005) 0.87

Who should be treated for Helicobacter pylori infection? A review of consensus conferences and guidelines. Gastroenterology (1997) 0.85

CagA-positive Helicobacter pylori infection is not associated with decreased risk of Barrett's esophagus in a population with high H. pylori infection rate. BMC Gastroenterol (2006) 0.84

Dyspepsia is associated with CagA-positive Helicobacter pylori. Am J Gastroenterol (2000) 0.79

Helicobacter pylori eradication does not worsen quality of life related to reflux symptoms: a prospective trial. Aliment Pharmacol Ther (2002) 0.78

Value of quantitative serology for confirmation of Helicobacter pylori eradication: an 18-month follow-up study. Clin Infect Dis (2000) 0.78

Articles by these authors

Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int (2003) 5.37

Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet (2009) 5.13

Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas. Gastroenterology (2013) 4.43

Interventions to prevent skin cancer by reducing exposure to ultraviolet radiation: a systematic review. Am J Prev Med (2004) 4.07

Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology (2007) 3.94

Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis (2003) 3.90

Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology (2003) 3.90

Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study. Hepatology (2013) 3.35

Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol (2004) 3.08

Life After Cancer Epidemiology (LACE) Study: a cohort of early stage breast cancer survivors (United States). Cancer Causes Control (2005) 2.94

Identification of cardioviruses related to Theiler's murine encephalomyelitis virus in human infections. Proc Natl Acad Sci U S A (2008) 2.84

Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr (2006) 2.67

Validity and reliability of the Block98 food-frequency questionnaire in a sample of Canadian women. Public Health Nutr (2006) 2.63

The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on real-time endoscopic assessment of the histology of diminutive colorectal polyps. Gastrointest Endosc (2011) 2.51

The complete genome of klassevirus - a novel picornavirus in pediatric stool. Virol J (2009) 2.46

Next generation genome-wide association tool: design and coverage of a high-throughput European-optimized SNP array. Genomics (2011) 2.31

Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. J Infect Dis (2005) 2.28

Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms. Gut (2006) 2.28

The effect of folate fortification of cereal-grain products on blood folate status, dietary folate intake, and dietary folate sources among adult non-supplement users in the United States. J Am Coll Nutr (2005) 2.18

Engaging students in dedicated research and scholarship during medical school: the long-term experiences at Duke and Stanford. Acad Med (2010) 2.12

Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006. Gut (2008) 2.08

The effect of breakfast type on total daily energy intake and body mass index: results from the Third National Health and Nutrition Examination Survey (NHANES III). J Am Coll Nutr (2003) 2.07

Prevention of vertical transmission of hepatitis B: an observational study. Ann Intern Med (2014) 2.05

Review of the toxicology of chlorpyrifos with an emphasis on human exposure and neurodevelopment. Crit Rev Toxicol (2008) 1.93

Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev (2008) 1.89

Reproducibility of QuantiFERON-TB gold in-tube assay. Clin Vaccine Immunol (2008) 1.86

Design and coverage of high throughput genotyping arrays optimized for individuals of East Asian, African American, and Latino race/ethnicity using imputation and a novel hybrid SNP selection algorithm. Genomics (2011) 1.78

Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. Gastroenterology (2001) 1.78

Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr (2004) 1.75

Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients. J Acquir Immune Defic Syndr (2010) 1.74

Smoking and exposure to environmental tobacco smoke decrease some plasma antioxidants and increase gamma-tocopherol in vivo after adjustment for dietary antioxidant intakes. Am J Clin Nutr (2003) 1.74

Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women's Health Across the Nation. Am J Epidemiol (2004) 1.73

CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma. Carcinogenesis (2002) 1.72

Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial. J Natl Cancer Inst (2008) 1.72

Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients. Nephrol Dial Transplant (2004) 1.71

Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection. Clin Infect Dis (2011) 1.68

Diagnosing Barrett's esophagus: reliability of clinical and pathologic diagnoses. Gastrointest Endosc (2009) 1.68

Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Gastroenterol (2006) 1.65

Activities Contributing to Total Energy Expenditure in the United States: Results from the NHAPS Study. Int J Behav Nutr Phys Act (2004) 1.64

Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States. Emerg Infect Dis (2004) 1.63

Investigation of false-positive results given by the QuantiFERON-TB Gold In-Tube assay. J Clin Microbiol (2012) 1.63

Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer. Breast Cancer Res Treat (2006) 1.59

Helicobacter pylori infection and gastric cancer--for want of more outcomes. JAMA (2004) 1.57

Commentary: H. pylori infection in early life and the problem of imperfect tests. Int J Epidemiol (2005) 1.57

Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut (2007) 1.57

Variability in antibiotic prescribing patterns and outcomes in patients with clinically suspected ventilator-associated pneumonia. Chest (2003) 1.56

Variation in nutrient intakes by ethnicity: results from the Study of Women's Health Across the Nation (SWAN). Menopause (2002) 1.56

Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. Gastroenterology (2010) 1.55

Pilot survey of HIV risk and contextual problems and issues in Mexican/Latino migrant day laborers. J Immigr Health (2005) 1.53

Discovery of a novel polyomavirus in acute diarrheal samples from children. PLoS One (2012) 1.48

Vitamin d deficiency and tuberculosis progression. Emerg Infect Dis (2010) 1.46

Methylphenidate use in children and risk of cancer at 18 sites: results of surveillance analyses. Pharmacoepidemiol Drug Saf (2007) 1.46

Mammographic density in a multiethnic cohort. Menopause (2007) 1.45

Infection with Helicobacter pylori is associated with protection against tuberculosis. PLoS One (2010) 1.45

Diagnostic X-rays and risk of childhood leukaemia. Int J Epidemiol (2010) 1.43

Nutritional factors and susceptibility to arsenic-caused skin lesions in West Bengal, India. Environ Health Perspect (2004) 1.38

Influence of site classification on cancer incidence rates: an analysis of gastric cardia carcinomas. J Natl Cancer Inst (2004) 1.38

Improving diet and physical activity with ALIVE: a worksite randomized trial. Am J Prev Med (2009) 1.37

Immediate incubation reduces indeterminate results for QuantiFERON-TB Gold in-tube assay. J Clin Microbiol (2010) 1.36

The association of time in the US and diet during pregnancy in low-income women of Mexican descent. Paediatr Perinat Epidemiol (2005) 1.35

Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization. Am J Gastroenterol (2000) 1.35

Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial. Cancer Epidemiol Biomarkers Prev (2004) 1.34

Encouraging scholarship: medical school programs to promote student inquiry beyond the traditional medical curriculum. Acad Med (2010) 1.33

Use of insecticide-treated nets (ITNs) following a malaria education intervention in Piron, Mali: a control trial with systematic allocation of households. Malar J (2005) 1.29

Food intake characteristics of hemodialysis patients as obtained by food frequency questionnaire. J Ren Nutr (2002) 1.24

Family history and colorectal cancer: predictors of risk. Cancer Causes Control (2003) 1.24

Dietary assessment of individuals with chronic kidney disease. Semin Dial (2010) 1.23

Malignant chondroid syringoma of the face: a first reported case. Otolaryngol Head Neck Surg (2005) 1.21

A global DNA methylation and gene expression analysis of early human B-cell development reveals a demethylation signature and transcription factor network. Nucleic Acids Res (2012) 1.21

Maternal dietary risk factors in childhood acute lymphoblastic leukemia (United States). Cancer Causes Control (2004) 1.20

CYP1A1, cigarette smoking, and colon and rectal cancer. Am J Epidemiol (2004) 1.20

Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus. Gastroenterology (2008) 1.19

Validation of diagnoses of peptic ulcers and bleeding from administrative databases: a multi-health maintenance organization study. J Clin Epidemiol (2002) 1.19

Does gamma-tocopherol play a role in the primary prevention of heart disease and cancer? A review. J Am Coll Nutr (2006) 1.19

Gastroenteritis and transmission of Helicobacter pylori infection in households. Emerg Infect Dis (2006) 1.18

Relations of glycemic index and glycemic load with plasma oxidative stress markers. Am J Clin Nutr (2006) 1.18

Development and reliability of brief dietary assessment tools for Hispanics. Prev Chronic Dis (2006) 1.18

Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Arch Surg (2006) 1.18

Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer. Breast Cancer Res Treat (2011) 1.16

Urinary triclosan is associated with elevated body mass index in NHANES. PLoS One (2013) 1.15

A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients. J Am Soc Nephrol (2004) 1.14

Helicobacter pylori infection and development of pancreatic cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.14

Nonlinearity in demographic and behavioral determinants of morbidity. Health Serv Res (2003) 1.13

Risk of intestinal helminth and protozoan infection in a refugee population. Am J Trop Med Hyg (2005) 1.11

Challenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers. Am J Respir Crit Care Med (2013) 1.11

Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review. Breast Cancer Res Treat (2012) 1.10

Helicobacter pylori infection and gender: a meta-analysis of population-based prevalence surveys. Dig Dis Sci (2006) 1.09

The nutritional status of astronauts is altered after long-term space flight aboard the International Space Station. J Nutr (2005) 1.09

Risk of subsequent cancer following invasive or in situ squamous cell skin cancer. Ann Epidemiol (2002) 1.09

Natural acquisition of Helicobacter pylori infection in newborn rhesus macaques. J Clin Microbiol (2003) 1.08

Citizen intervention in a religious ban on in-school HPV vaccine administration in Calgary, Canada. Prev Med (2013) 1.08

Antioxidant supplementation decreases lipid peroxidation biomarker F(2)-isoprostanes in plasma of smokers. Cancer Epidemiol Biomarkers Prev (2002) 1.07

Determinants of polycyclic aromatic hydrocarbon levels in house dust. J Expo Sci Environ Epidemiol (2009) 1.06

Significance of transiently positive enzyme-linked immunosorbent assay results in detection of Helicobacter pylori in stool samples from children. J Clin Microbiol (2005) 1.05